HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

16.090

0.000

Volume:325.10K

Turnover:5.21M

Market Cap:5.21B

PE:-11.83

High:16.650

Open:16.650

Low:15.880

Close:16.090

52wk High:206.000

52wk Low:15.670

Shares:324.00M

HK Float Shares:153.00M

Volume Ratio:1.31

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.360

ROE:-30.55%

ROA:-10.79%

PB:2.81

PE(LYR):-11.83

PS:90.89

Loading ...

Overview Company News Filings

BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10

Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity

Bulletin Express

Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share

BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval

BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback

Bulletin Express

BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8

Bao Pharma appoints new joint company secretary and secures Listing Rules waiver

Bulletin Express

BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary

Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent

Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600

Bulletin Express

BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6

Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares

Bulletin Express

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65

Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection

BAO PHARMA-B Surges Over 10% In Session Following Clinical Trial Approval for Recombinant Ulinastatin

Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%

Bulletin Express

BAO PHARMA-B (02659) Repurchases 95,200 Shares for Approximately HK$1.686 Million on June 30

Shanghai Bao Pharma Files HKEX Next-day Disclosure on Share Buyback at HKD 17.38-17.81

Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection

Yidu Tech Achieves Historic Annual Profit Turnaround; Key HKEX Announcements on M&A, Clinical Trials, and AI Partnerships

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02659/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":16.09,"timestamp":1787299687043,"preClose":16.09,"halted":0,"volume":325100,"delay":0,"changeRate":0,"floatShares":153000000,"shares":324000000,"eps":-1.36,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:08:07","open":16.65,"high":16.65,"low":15.88,"amount":5214062,"amplitude":0.047856,"askPrice":16.21,"askSize":100,"bidPrice":16.09,"bidSize":12800,"shortable":0,"etf":0,"ttmEps":-1.35,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":16.09,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.313981310032103,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":153000000,"roa":"-10.79%","roe":"-30.55%","lyrEps":-1.36,"volumeRatio":1.313981310032103,"shares":324000000,"dividePrice":0,"high":16.65,"amplitude":0.047856,"preClose":16.09,"low":15.88,"week52Low":15.67,"pbRate":"2.81","psRate":"90.89","week52High":206,"institutionHeld":0,"latestPrice":16.09,"committee":0.984496,"eps":-1.36,"divideRate":0,"volume":325100,"delay":0,"ttmEps":-1.35,"open":16.65,"prevYearClose":77.55,"prevWeekClose":16.9,"prevMonthClose":17.25,"prevQuarterClose":18,"fiveDayClose":16.9,"twentyDayClose":17.25,"sixtyDayClose":25.68,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-26","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1779984000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-08-21","current":-11.918519,"percent":1,"low":-150.791275,"twenty":-75.31975,"median":-54.455852,"eighty":-13.139203,"high":-11.379099,"avg":-48.460281,"sd":35.791886,"marketCap":5245041771},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-20","current":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"marketCap":59426421069},{"date":"2026-02-27","current":-116.132786,"twenty":-104.714701,"median":-73.426035,"eighty":-56.395698,"marketCap":50494528928},{"date":"2026-03-06","current":-76.640212,"twenty":-111.983375,"median":-74.892856,"eighty":-56.998352,"marketCap":33054520551},{"date":"2026-03-13","current":-75.987902,"twenty":-110.582832,"median":-75.36732,"eighty":-57.563278,"marketCap":32924127965},{"date":"2026-03-20","current":-70.725897,"twenty":-109.509649,"median":-74.892856,"eighty":-57.733099,"marketCap":30528164197},{"date":"2026-03-27","current":-65.400661,"twenty":-104.714701,"median":-74.674242,"eighty":-58.326024,"marketCap":29273135557},{"date":"2026-04-02","current":-74.510382,"twenty":-96.653813,"median":-73.605533,"eighty":-59.04256,"marketCap":33510894602},{"date":"2026-04-10","current":-71.602503,"twenty":-91.308972,"median":-74.057958,"eighty":-59.568794,"marketCap":32451454840},{"date":"2026-04-17","current":-64.454748,"twenty":-86.399914,"median":-73.087213,"eighty":-60.479603,"marketCap":29224238337},{"date":"2026-04-24","current":-55.967849,"twenty":-84.718643,"median":-71.1642,"eighty":-60.173931,"marketCap":25377657050},{"date":"2026-04-30","current":-18.543355,"twenty":-83.426575,"median":-70.300184,"eighty":-58.506399,"marketCap":8410321797},{"date":"2026-05-08","current":-19.625214,"twenty":-81.092081,"median":-69.74185,"eighty":-56.760202,"marketCap":8931892141},{"date":"2026-05-15","current":-17.930681,"twenty":-79.944236,"median":-68.961959,"eighty":-55.831299,"marketCap":8182134771},{"date":"2026-05-22","current":-17.55647,"twenty":-79.579829,"median":-66.237091,"eighty":-53.674239,"marketCap":7993065521},{"date":"2026-05-29","current":-17.509903,"twenty":-78.962132,"median":-66.085797,"eighty":-51.516739,"marketCap":7999585151},{"date":"2026-06-05","current":-15.389804,"twenty":-78.220574,"median":-65.202887,"eighty":-19.743808,"marketCap":7041199644},{"date":"2026-06-12","current":-13.774642,"twenty":-77.936107,"median":-64.592987,"eighty":-19.178821,"marketCap":6297961903},{"date":"2026-06-18","current":-12.785133,"twenty":-77.726882,"median":-64.454748,"eighty":-18.7468,"marketCap":5857886926},{"date":"2026-06-26","current":-11.736313,"twenty":-77.358698,"median":-62.675612,"eighty":-18.25553,"marketCap":5352615655},{"date":"2026-07-03","current":-13.348826,"twenty":-77.285436,"median":-61.290684,"eighty":-17.828553,"marketCap":6092593580},{"date":"2026-07-10","current":-14.187594,"twenty":-77.122448,"median":-60.663453,"eighty":-17.509903,"marketCap":6467472265},{"date":"2026-07-17","current":-12.348746,"twenty":-76.777398,"median":-59.36056,"eighty":-15.389804,"marketCap":5649258788},{"date":"2026-07-24","current":-12.28898,"twenty":-76.640212,"median":-57.965274,"eighty":-14.102609,"marketCap":5623180271},{"date":"2026-07-31","current":-12.265678,"twenty":-76.228711,"median":-57.553252,"eighty":-13.925373,"marketCap":5623180271},{"date":"2026-08-07","current":-12.759971,"twenty":-76.015489,"median":-56.434485,"eighty":-13.758151,"marketCap":5861146740},{"date":"2026-08-14","current":-11.978357,"twenty":-75.491436,"median":-55.967849,"eighty":-13.50755,"marketCap":5509086758},{"date":"2026-08-21","current":-11.379099,"twenty":-75.31975,"median":-54.455852,"eighty":-13.139203,"marketCap":5245041771}],"updateTime":1787459342637},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166944628","title":"BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1166944628","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166944628?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:07","pubTimestamp":1783678070,"startTime":"0","endTime":"0","summary":"The company announced that on July 10, 2026, it repurchased 149,800 shares at a total cost of HK$2.9929 million.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111716596","title":"Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=1111716596","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111716596?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:06","pubTimestamp":1783595182,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a repurchase of 153,200 H-shares on 9 July 2026, executed on the Hong Kong Stock Exchange. The transaction was completed at prices...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650925679","title":"Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2650925679","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650925679?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:38","pubTimestamp":1783593502,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX return disclosing share buyback at HKD 19.53 per shareShanghai Bao Pharmaceuticals repurchased 153,200 H shares on July 9, 2026 for treasury, with no shares bought for c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL82tvdg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156096333","title":"BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1156096333","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156096333?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563677,"startTime":"0","endTime":"0","summary":"Shares of BAO PHARMA-B (02659) surged more than 6% in early trading. At the time of writing, the stock is up 2.76%, trading at HK$20.10 with a turnover of HK$7.1887 million. In late June, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160306991","title":"BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1160306991","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160306991?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:03","pubTimestamp":1783508600,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session. • Transaction...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114896920","title":"BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1114896920","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114896920?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:50","pubTimestamp":1783507837,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has disclosed details of a recent share buyback transaction.The company announced that on July 8, 2026, it executed a repurchase of 145,600 of its own shares.The total...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131855067","title":"Bao Pharma appoints new joint company secretary and secures Listing Rules waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=1131855067","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131855067?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:03","pubTimestamp":1783504997,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168820240","title":"BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1168820240","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168820240?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:55","pubTimestamp":1783504559,"startTime":"0","endTime":"0","summary":"BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649962199","title":"Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2649962199","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649962199?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:50","pubTimestamp":1783504205,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma appoints Tsang Chun Ho as joint company secretary, authorized representative and process agentShanghai Bao Pharmaceuticals appointed Tsang Chun Ho as joint company secretary, autho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL1kRccX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122343240","title":"Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600","url":"https://stock-news.laohu8.com/highlight/detail?id=1122343240","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122343240?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:04","pubTimestamp":1783422249,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a next-day return showing an on-market repurchase of 137,300 H-shares on 7 July 2026. • Transaction details: Shares were bought back on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183461123","title":"BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6","url":"https://stock-news.laohu8.com/highlight/detail?id=1183461123","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183461123?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:11","pubTimestamp":1783336260,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (ASX: 02659) announced that on July 6, 2026, the company executed a share repurchase. The transaction involved approximately 52,100 shares at a total cost of about HK$971,400. The repurchase price per share ranged from HK$18.19 to HK$18.68.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113048495","title":"Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1113048495","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113048495?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:07","pubTimestamp":1783336024,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (“Bao Pharma”) reported a share buyback on 6 July 2026, purchasing 52,100 H-shares on the Hong Kong Stock Exchange for an aggregate HK$0.97 million. The shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649255276","title":"Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2649255276","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649255276?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:58","pubTimestamp":1783335534,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals files HKEX next-day disclosure after share buyback at HKD 18.65Shanghai Bao Pharmaceuticals repurchased 52,100 H shares on July 6, 2026 for treasury; no shares were repurc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL89P23T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649964964","title":"Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2649964964","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649964964?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:15","pubTimestamp":1783322126,"startTime":"0","endTime":"0","summary":"June 30 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd <2659.HK>::*NMPA APPROVES IND APPLICATION FOR BJ044 INJECTION, PERMITTING CLINICAL TRIALS*Further company coverage: 2659.HK* ((Reuters.Briefs@th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD8BSg84:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166966432","title":"BAO PHARMA-B Surges Over 10% In Session Following Clinical Trial Approval for Recombinant Ulinastatin","url":"https://stock-news.laohu8.com/highlight/detail?id=1166966432","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166966432?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:02","pubTimestamp":1783044169,"startTime":"0","endTime":"0","summary":"Shares of BAO PHARMA-B (02659) climbed more than 10% during the trading session. At the time of writing, the stock is up 4.82%, trading at HK$18.92 with a turnover of HK$8.4168 million. The company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119988416","title":"Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119988416","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119988416?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:04","pubTimestamp":1782817473,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange. The shares were repurchased at prices between...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153676444","title":"BAO PHARMA-B (02659) Repurchases 95,200 Shares for Approximately HK$1.686 Million on June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1153676444","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153676444?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:54","pubTimestamp":1782816873,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on June 30, 2026, the company repurchased 95,200 of its own shares at a total cost of approximately HK$1.686 million.The share buyback was executed at prices ranging from HK$17.38 to HK$17.81 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537020","title":"Shanghai Bao Pharma Files HKEX Next-day Disclosure on Share Buyback at HKD 17.38-17.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537020","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647537020?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:50","pubTimestamp":1782816637,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day disclosure on share buyback at HKD 17.38-17.81Shanghai Bao Pharmaceuticals repurchased 95,200 H shares on June 30, 2026 for treasury, with no shares cancelled.B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4hrxhR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647728585","title":"Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2647728585","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647728585?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:40","pubTimestamp":1782783652,"startTime":"0","endTime":"0","summary":"June 30 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd <2659.HK>::*NMPA APPROVES IND APPLICATION FOR BJ044 INJECTION, PERMITTING CLINICAL TRIALS*Further company coverage: 2659.HK* ((Reuters.Briefs@th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nRSD8BSg84:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173979252","title":"Yidu Tech Achieves Historic Annual Profit Turnaround; Key HKEX Announcements on M&A, Clinical Trials, and AI Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=1173979252","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173979252?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:10","pubTimestamp":1782781850,"startTime":"0","endTime":"0","summary":"Key corporate developments have been announced across the Hong Kong market. Bao Pharma-B (HKEX: 02659) reported that the clinical trial application for its BJ044 injection (recombinant ulinastatin)...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","01783","BK1144","BK1148","BK1149","BK1189","02431","BK1518","BK1617","BK1161","00638","02158","BK1214","02659","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":119,"code":"91000000","status":"200"}]}}